blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0678027

EP0678027 - ANTI-ATHEROSCLEROTIC AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.10.2002
Database last updated on 05.10.2024
Most recent event   Tooltip18.10.2002Lapse of the patent in a contracting statepublished on 04.12.2002  [2002/49]
Applicant(s)For all designated states
American Home Products Corporation
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
[N/P]
Former [1995/43]For all designated states
AMERICAN HOME PRODUCTS CORPORATION
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Inventor(s)01 / ADELMAN, Steven Jay
342 Windy Run Drive
Doylestown, PA 18901 / US
02 / STEINER, Kurt Edric
15 Woodlane Road
Lawrenceville, NJ 08648 / US
[1995/43]
Representative(s)Connelly, Michael John, et al
C/o Patent Department Wyeth Laboratories Huntercombe Lane South Taplow
Maidenhead Berkshire SL6 0PH / GB
[N/P]
Former [1995/43]Connelly, Michael John, et al
c/o Patent Department Wyeth Laboratories Huntercombe Lane South Taplow
Maidenhead Berkshire SL6 0PH / GB
Application number, filing date94906461.222.12.1993
[1995/43]
WO1993US12559
Priority number, dateUS1993000077705.01.1993         Original published format: US 777
US1993015766101.12.1993         Original published format: US 157661
[1995/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9415612
Date:21.07.1994
Language:EN
[1994/17]
Type: A1 Application with search report 
No.:EP0678027
Date:25.10.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 21.07.1994 takes the place of the publication of the European patent application.
[1995/43]
Type: B1 Patent specification 
No.:EP0678027
Date:28.11.2001
Language:EN
[2001/48]
Search report(s)International search report - published on:EP21.07.1994
ClassificationIPC:A61K31/56
[1995/43]
CPC:
A61K31/56 (EP); A61K31/565 (EP); A61P9/10 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1995/43]
TitleGerman:ANTIATHEROSCLEROTISCHE MITTEL[1995/43]
English:ANTI-ATHEROSCLEROTIC AGENTS[1995/43]
French:AGENTS ANTIATHEROSCLEREUX[1995/43]
Entry into regional phase02.06.1995National basic fee paid 
02.06.1995Designation fee(s) paid 
02.06.1995Examination fee paid 
Examination procedure11.07.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.06.1995Examination requested  [1995/43]
17.05.2000Despatch of a communication from the examining division (Time limit: M02)
25.05.2000Reply to a communication from the examining division
11.01.2001Despatch of communication of intention to grant (Approval: Yes)
31.05.2001Communication of intention to grant the patent
29.08.2001Fee for grant paid
29.08.2001Fee for publishing/printing paid
Opposition(s)29.08.2002No opposition filed within time limit [2002/47]
Fees paidRenewal fee
19.10.1995Renewal fee patent year 03
16.10.1996Renewal fee patent year 04
18.10.1997Renewal fee patent year 05
16.10.1998Renewal fee patent year 06
06.12.1999Renewal fee patent year 07
07.12.2000Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGR28.11.2001
[2002/49]
Cited inInternational search[Y]US3507889  (MARSHALL DAVID J) [Y] 1-19 * example 9 *;
 [A]US3608075  (GLEN WILLIAM L, et al) [A] 1-31* column W *;
 [X]US4154820  (SIMOONS JOHAN R A [US]) [X] 1-8,13-19 * claim 1 *;
 [Y]US4379780  (RAO PEMMARAJU N) [Y] 1-19 * the whole document *
 [DXY]  - R. P. HOWARD ET AL., "Evaluation of equilin 3-monosulfate and other estrogens", ARCH. INTERN. MED., (1971), vol. 128, pages 229 - 234 [DX] 1-8,13-19 * table 3 * [Y] 20-31
 [DXY]  - M.D. STERN, "Pharmacology of conjugated oestrogens", MATURITAS, (1982), vol. 4, pages 333 - 339 [DX] 1-8,13-19 * tables I,II * [Y] 20-31
 [Y]  - F. NUMANO ET AL., "On the mechanism of antiatherosclerotic agents: Microchemical studies on the in vitro effects of pyridinol carbamate and estrogen (premarin) on phosphofructokinase and malate dehydrogenase in the arterial wall", MECH. AGEING DEV., (1973), vol. 2, no. 1, pages 43 - 53 [Y] 20-31 * the whole document *
 [Y]  - S. RENAUD, "Thrombosis and atherosclerosis prevention by estrogens in hyperlipemic rats", ATHEROSCLEROSIS, (1970), vol. 12, no. 3, pages 467 - 473 [Y] 20-31 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.